Humacyte Historical Financial Ratios
| HUMAW Stock | USD 1.95 0.10 5.41% |
Humacyte is recently reporting on over 82 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 22.77 or Days Sales Outstanding of 7.9 will help investors to properly organize and evaluate Humacyte financial condition quickly.
Humacyte |
About Humacyte Financial Ratios Analysis
HumacyteFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Humacyte investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Humacyte financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Humacyte history.
Humacyte Financial Ratios Chart
Add Fundamental
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Roic
Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Average Inventory
The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.Most ratios from Humacyte's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Humacyte current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humacyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.At this time, Humacyte's PTB Ratio is fairly stable compared to the past year. Book Value Per Share is likely to climb to 0.14 in 2024, whereas Days Sales Outstanding is likely to drop 7.90 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 8.04 | 3.99 | 1.78 | 1.69 | Receivables Turnover | 7.18 | 50.48 | 45.44 | 47.71 |
Humacyte fundamentals Correlations
Click cells to compare fundamentals
Humacyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Humacyte Stock Analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.